Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 3 1

Status

Completed 3

Sponsor Class

INDUSTRY 326NIH 8NETWORK 7OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

CNS 1

Conditions

Recurrence 1Neuroblastoma 1Neoplasms 1Graft vs Host Disease 1

Interventions

Eflornithine 1Drug Therapy 1Abatacept 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Has results × Has announcements × Clear all
NCT01743131 2025-12-11

Abatacept as GVHD Prophylaxis Phase 2

Boston Children's Hospital

Phase 2 Completed
186 enrolled 14 charts 1 FDA

Graft vs Host Disease, Neoplasms

NCT03581786 2025-09-02

The Efficacy and Safety Study of TORIPALIMAB INJECTION Combined With Chemotherapy for Nasophapyngeal Cancer

Shanghai Junshi Bioscience Co., Ltd.

Phase 3 Completed
289 enrolled 32 charts 1 FDA

Recurrence

NCT02395666 2024-08-06

Preventative Trial of Difluoromethylornithine (DFMO) in High Risk Patients With Neuroblastoma That is in Remission

Milton S. Hershey Medical Center

Phase 2 Completed
140 enrolled 14 charts 1 FDA
CNS

Neuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡